Clinical Trial Update: Prevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on prevention of autoimmune destruction and rejection of transplanted human pancreatic islets in insulin-dependent diabetes mellitus (Type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of California, San Francisco | Conditions: Type 1 Diabetes | Phase 1, Phase 2 | Status: COMPLETED